Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC
Clinical trial NCT05171309 · UNKNOWN
Trial details
- NCT number
- NCT05171309
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.